 |
|
Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women
Nayoung Kim, Ha-Na Yoo, Hye Sun Hyun, Dong-Yun Lee, Byung-Koo Yoon, Doo-Seok Choi
Obstet Gynecol Sci. 2015;58(5):397-400. Published online 2015 Sep 22 DOI: https://doi.org/10.5468/ogs.2015.58.5.397
|
|
Citations to this article as recorded by
 Safety and Efficacy of Combined Oral Contraceptive Ethinyl Estradiol/Drospirenone (YAZ) in Chinese Women: A Single-Arm, Open-Label, Multicenter, Post-Authorization Study
Xin Sun, Fangbo Qian, Yaojuan He, Xiangying Gu, Wen Di
Advances in Therapy.2020; 37(2): 906. CrossRef Progesterone – Friend or foe?
Inger Sundström-Poromaa, Erika Comasco, Rachael Sumner, Eileen Luders
Frontiers in Neuroendocrinology.2020; 59: 100856. CrossRef FSRH Guideline (January 2019, amended November 2020) Combined Hormonal Contraception
BMJ Sexual & Reproductive Health.2019; 45(Suppl 1): 1. CrossRef Synthetic Hormones and Clot Formation
Albe C. Swanepoel, Amcois Visagie, Etheresia Pretorius
Microscopy and Microanalysis.2016; 22(4): 878. CrossRef
|